In light of promising initial evidence of X chromosome genetic and gene expression associations with AD biomarkers and pathology,56,57 as well as observations of sex differences in tau pathology and the genetics of tau pathology,16,49,58,59 there is, additionally, a need to more broadly explore the role of X chromosome genetics in AD pathogenesis rather than just AD risk. Here, MAPT is linked to Alzheimer disease.